Achievement of >= 20/40 vision with ranibizumab in patients with diabetic macular edema: a post-hoc analysis of the RESTORE study

Chong Victor; Alsop Jonathan; Margaron Philippe; Mitchell Paul

首页> 外文期刊>Investigative ophthalmology & visual science >Achievement of >= 20/40 vision with ranibizumab in patients with diabetic macular edema: a post-hoc analysis of the RESTORE study

【24h】

Achievement of >= 20/40 vision with ranibizumab in patients with diabetic macular edema: a post-hoc analysis of the RESTORE study

机译：患有> = 20/40患者患有糖尿病性黄斑水肿患者的20/40视野：恢复研究的后HOC分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2016年第12期|共3页
作者
Chong Victor; Alsop Jonathan; Margaron Philippe; Mitchell Paul;
展开▼
作者单位

Oxford Eye Hosp Oxford England;

Numerus Ltd Wokingham Berks England;

Novartis Pharma AG Basel Switzerland;

Univ Sydney Westmead Millennium Inst Dept Ophthalmol Ctr Vis Res Sydney NSW Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Achievement of >= 20/40 vision with ranibizumab in patients with diabetic macular edema: a post-hoc analysis of the RESTORE study [J] . Chong Victor, Alsop Jonathan, Margaron Philippe, Investigative ophthalmology & visual science . 2016,第12期

机译：患有> = 20/40患者患有糖尿病性黄斑水肿患者的20/40视野：恢复研究的后HOC分析
2. Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema Report From RESTORE, RIDE, and RISE Trials [J] . Bressler Neil M., Varma Rohit, Mitchell Paul, JAMA ophthalmology . 2016,第2期

机译：RESTORE，RIDE和RISE试验报告，雷珠单抗对糖尿病性黄斑水肿患者的驾驶决策和与驾驶相关的视觉功能的影响
3. Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study [J] . Mitchell Paul, Massin Pascale, Bressler Susan, Current medical research and opinion . 2015,第11期

机译：使用兰尼单抗治疗的三年期患者报告的糖尿病性黄斑水肿视功能预后：RESTORE扩展研究
4. Inter-observer Reliability and Agreement Study on Early Diagnosis of Diabetic Retinopathy and Diabetic Macular Edema Risk [C] . Manuel Emilio Gegundez-Arias, Carlos Ortega, Javier Garrido, International Conference on Bioinformatics and Biomedical Engineering . 2016

机译：糖尿病视网膜病变和黄斑水肿风险的早期诊断的观察者间可靠性和一致性研究
5. Prediction of visual acuity loss and indications for laser treatment in patients with diabetic macular edema using the Heidelberg Retina Tomograph. [D] . O'Neal, Dennis A. 2007

机译：使用海德堡视网膜断层扫描仪预测糖尿病性黄斑水肿患者的视力下降和激光治疗的适应症。
6. Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study) [O] . Elisabeth Van Aken, Mérédis Favreau, Eva Ramboer, 2020

机译：糖尿病黄斑水肿患者的现实世界结果与Ranibizumab（视觉研究）治疗长期
7. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study [O] . Schmidt-Erfurth, Ursula, Lang, Gabriele E., Holz, Frank G., 2017

机译：个体化雷珠单抗治疗糖尿病性黄斑水肿患者的三年结果：REsTORE扩展研究

Achievement of >= 20/40 vision with ranibizumab in patients with diabetic macular edema: a post-hoc analysis of the RESTORE study

著录项

相似文献

相关主题

期刊订阅